These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 6961721)
1. Histochemical determination of estrogen and progesterone binding in fine needle aspirates of breast cancer. Correlation with conventional biochemical assays. Curtin CT; Pertschuk LP; Mitchell V Acta Cytol; 1982; 26(6):841-6. PubMed ID: 6961721 [TBL] [Abstract][Full Text] [Related]
2. Comparison of histochemical and biochemical methods in the evaluation of estrogen and progesterone receptor level in human breast cancer. A study of 118 cases. Mohácsy J; Kádár A; Vallent K; Duffek L; Vass K Acta Chir Hung; 1988; 29(1):95-105. PubMed ID: 2455948 [TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients. Nizzoli R; Bozzetti C; Savoldi L; Manotti L; Naldi N; Camisa R; Soresi AP; Guazzi A; Cocconi G Acta Cytol; 1994; 38(6):933-8. PubMed ID: 7992582 [TBL] [Abstract][Full Text] [Related]
4. A histochemical technique for evaluation of progesterone receptors in breast cancer. Pertschuk LP; Tobin EH; Gaetjens E; Degenshein GA; Autuoro LM; Brigati DJ; Bloom ND; Carter AC; Rainford EA Res Commun Chem Pathol Pharmacol; 1979 Mar; 23(3):635-8. PubMed ID: 461981 [TBL] [Abstract][Full Text] [Related]
5. Estrogen and progesterone receptors in human breast cancer with concomitant assay of plasma 17beta-estradiol, progesterone, and prolactin levels. Nagai R; Kataoka M; Kobayashi S; Ishihara K; Tobioka N; Nakashima K; Naruse M; Saito K; Sakuma S Cancer Res; 1979 May; 39(5):1834-40. PubMed ID: 427816 [TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical determination of estrogen and progesterone receptors and flow cytometric DNA analysis of breast cancer on fine needle aspirates. Marrazzo A; Russo A; Bazan V; Taormina P; Lupo F; Bazan P Anticancer Res; 1993; 13(6B):2435-40. PubMed ID: 8135480 [TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of oestrogen and progesterone receptors on fine-needle aspirates and cryostat sections of breast carcinomas: how does this compare with biochemical assays? Muchiri LW East Afr Med J; 1993 May; 70(5):280-3. PubMed ID: 8306903 [TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical determination of estrogen and progesterone receptors on 219 fine-needle aspirates of breast cancer. A prospective study. Marrazzo A; Taormina P; Leonardi P; Lupo F; Filosto S Anticancer Res; 1995; 15(2):521-6. PubMed ID: 7763033 [TBL] [Abstract][Full Text] [Related]
9. Histochemical assay of estrogen and progesterone receptors in breast cancer: correlation with biochemical assays and patients' response to endocrine therapies. Pertschuk LP; Tobin EH; Gaetjens E; Carter AC; Degenshein GA; Bloom ND; Brigati DJ Cancer; 1980 Dec; 46(12 Suppl):2896-901. PubMed ID: 6256056 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of estrogen receptors in cells obtained by fine needle aspiration from human mammary carcinomas. Azavedo E; Baral E; Skoog L Anticancer Res; 1986; 6(2):263-6. PubMed ID: 3518595 [TBL] [Abstract][Full Text] [Related]
11. [Determination of cytoplasmic estrogen and progesterone receptors in breast carcinoma: comparison of a histochemical and a radiometric method]. Wolf D; Forti E; Gion M; Melia M; Dittadi R; Mione R Pathologica; 1985; 77(1049):305-9. PubMed ID: 3831881 [No Abstract] [Full Text] [Related]
12. Fluorescent cytochemical detection of estrogen and progesterone receptors in breast fine-needle aspirates. Masood S Am J Clin Pathol; 1991 Jan; 95(1):35-40. PubMed ID: 1987750 [TBL] [Abstract][Full Text] [Related]
13. Fluoresceinated estrone binding by human and mouse breast cancer cells. Fisher B; Gunduz N; Zheng S; Saffer EA Cancer Res; 1982 Feb; 42(2):540-9. PubMed ID: 7055802 [No Abstract] [Full Text] [Related]
14. Relationship of cytoplasmic and nuclear estrogen receptors and progesterone receptors in human breast cancer. Romić-Stojković R; Gamulin S Cancer Res; 1980 Dec; 40(12):4821-5. PubMed ID: 7438115 [TBL] [Abstract][Full Text] [Related]
15. Implications of subcellular steroid binding sites in endometrial cancer, determined by an immunofluorescent steroid-antibody technique and biochemical assay. Tamaya T; Kimura J; Tsurusaki T; Kato Y; Fujimoto J; Okada H Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jan; 36(1):113-8. PubMed ID: 6366089 [TBL] [Abstract][Full Text] [Related]
16. [Studies on the mechanism of the estrogen action in human breast cancer]. Kimura M; Nishimura R; Akagi M Gan No Rinsho; 1985 Mar; 31(3):263-7. PubMed ID: 3999388 [TBL] [Abstract][Full Text] [Related]
17. [Degree of manifestation of therapeutic pathomorphosis and the nature of the change in the estrogen and progesterone receptors after the radiation and chemotherapy of breast cancer]. Ermilova VD; Koposova TL; Murav'ëva NI; Kuz'mina ZV Vopr Onkol; 1985; 31(12):69-73. PubMed ID: 4082510 [TBL] [Abstract][Full Text] [Related]
18. Histochemistry of steroid receptors in breast cancer: an overview. Pertschuk LP; Gaetjens E; Carter AC; Brigati DJ; Kim DS; Tobin EH Ann Clin Lab Sci; 1979; 9(3):219-24. PubMed ID: 380449 [TBL] [Abstract][Full Text] [Related]
19. [Drill biopsy and puncture biopsy for the determination of hormone receptors]. Magdelenat H Pathol Biol (Paris); 1983 Nov; 31(9):755-60. PubMed ID: 6361673 [TBL] [Abstract][Full Text] [Related]
20. Failure of estradiol immunofluorescence in MCF-7 breast cancer cells to detect estrogen receptors. Mercer WD; Edwards DP; Chamness GC; McGuire WL Cancer Res; 1981 Nov; 41(11 Pt 1):4644-52. PubMed ID: 7030480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]